Zentalis Pharmaceuticals, Inc.

ZNTL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001725160

SEC filings (opens in a new tab)

In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Zentalis Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of ZNTL: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	145	1	136	−8
Shares	76.7M	4.82M	71.0M	−881.3K (−1.2%)
Value	$314.3M	$19.7M	$261.2M	−$33.4M (−11.3%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Zentalis Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ZNTL in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	4,761,173	$17.5M	0.00%
Opaleye Management Inc.	967,000	$3.56M	0.59%
Almitas Capital LLC	960,928	$3.54M	1.25%
Acadian Asset Management LLC	263,216	$967.0K	0.00%
AQR Capital Management LLC	195,482	$719.4K	0.00%
HRT Financial LP	78,927	$290.0K	0.00%
Man Group plc	54,459	$200.4K	0.00%
Tudor Investment Corp Et Al	35,709	$131.4K	0.00%
Jump Financial, LLC	33,557	$123.5K	0.00%
Group One Trading, L.P.	29,800	$109.7K	0.00%
Nebula Research & Development LLC	29,191	$107.4K	0.01%
Dark Forest Capital Management LP	25,706	$94.6K	0.01%
Martingale Asset Management L P	24,712	$90.9K	0.00%
Russell Investments Group, Ltd.	22,295	$82.0K	0.00%
Intech Investment Management LLC	20,407	$75.1K	0.00%
State of Wyoming	15,454	$56.9K	0.01%
Prelude Capital Management, LLC	15,210	$56.0K	0.00%
Quarry LP	15,000	$55.2K	0.02%
Capstone Investment Advisors, LLC	13,066	$48.1K	0.00%
Aigen Investment Management, LP	11,054	$40.7K	0.01%
Paloma Partners Management Co	10,024	$36.9K	0.00%
nVerses Capital, LLC	3,100	$11.4K	0.01%
Bryn Mawr Trust Co	1,000	$3.68K	0.00%
Clear Street Markets LLC	145	$1.00K	0.00%
True Wealth Design, LLC	211	$777	0.00%
Sterling Capital Management LLC	181	$666	0.00%
Capital Performance Advisors LLP	78	$287	0.00%

Sold out (35)

Institutions that held Zentalis Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ZNTL in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
T. Rowe Price Investment Management, Inc.	1,325,491	$5.42M
Capital International Investors	675,371	$2.76M
Bank of Montreal	98,331	$1.13M
Rafferty Asset Management, LLC	167,564	$685.3K
UBS Asset Management Americas Inc	113,386	$463.7K
Swiss National Bank	104,700	$428.2K
Virtu Financial LLC	93,186	$381.0K
Norges Bank	71,527	$292.5K
Prospera Financial Services Inc	48,780	$199.5K
Fox Run Management, L.L.C.	40,067	$163.9K
Pennant Investors, LP	32,400	$132.5K
State of Wisconsin Investment Board	32,052	$131.1K
Profund Advisors LLC	30,892	$126.3K
Schroder Investment Management Group	29,697	$124.7K
Wellington Management Group LLP	24,301	$99.4K
Walleye Capital LLC	22,021	$90.1K
Janus Henderson Group PLC	21,172	$86.7K
Occudo Quantitative Strategies LP	21,011	$85.9K
Corton Capital Inc.	20,185	$82.6K
Arizona State Retirement System	14,898	$60.9K
Engineers Gate Manager LP	14,637	$59.9K
Omers Administration Corp	14,500	$59.3K
Cornercap Investment Counsel Inc	12,582	$51.5K
Toroso Investments, LLC	12,518	$51.2K
Teacher Retirement System of Texas	11,684	$48.0K
E Fund Management Co., Ltd.	10,177	$41.6K
Zurcher Kantonalbank (Zurich Cantonalbank)	7,809	$31.9K
Great West Life Assurance Co	5,018	$21.0K
Innealta Capital, LLC	4,038	$16.5K
Catalyst Funds Management Pty Ltd	3,500	$14.3K
Pacer Advisors, Inc.	953	$3.90K
C M Bidwell & Associates Ltd	436	$1.78K
Lindbrook Capital, LLC	254	$1.04K
Quadrant Capital Group LLC	24	$99
GAMMA Investing LLC	2	$8

Not filed for Q3 2024 yet (1)

Institutions that held Zentalis Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZNTL in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	4,818,546	$19.7M